460 related articles for article (PubMed ID: 19500466)
1. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.
Amann B; Luedemann C; Ratei R; Schmidt-Lucke JA
Cell Transplant; 2009; 18(3):371-80. PubMed ID: 19500466
[TBL] [Abstract][Full Text] [Related]
2. [Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia].
Amann B; Lüdemann C; Ratei R; Schmidt-Lucke JA
Zentralbl Chir; 2009 Aug; 134(4):298-304. PubMed ID: 19688676
[TBL] [Abstract][Full Text] [Related]
3. Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease.
Franz RW; Parks A; Shah KJ; Hankins T; Hartman JF; Wright ML
J Vasc Surg; 2009 Dec; 50(6):1378-90. PubMed ID: 19837539
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
[TBL] [Abstract][Full Text] [Related]
5. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).
Amann B; Lüdemann C; Rückert R; Lawall H; Liesenfeld B; Schneider M; Schmidt-Lucke J
Vasa; 2008 Nov; 37(4):319-25. PubMed ID: 19003741
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia.
Napoli C; Farzati B; Sica V; Iannuzzi E; Coppola G; Silvestroni A; Balestrieri ML; Florio A; Matarazzo A
Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):709-18. PubMed ID: 19050436
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia.
Madaric J; Klepanec A; Valachovicova M; Mistrik M; Bucova M; Olejarova I; Necpal R; Madaricova T; Paulis L; Vulev I
Stem Cell Res Ther; 2016 Aug; 7(1):116. PubMed ID: 27530339
[TBL] [Abstract][Full Text] [Related]
8. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.
Murphy MP; Lawson JH; Rapp BM; Dalsing MC; Klein J; Wilson MG; Hutchins GD; March KL
J Vasc Surg; 2011 Jun; 53(6):1565-74.e1. PubMed ID: 21514773
[TBL] [Abstract][Full Text] [Related]
10. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
Gabr H; Hedayet A; Imam U; Nasser M
Exp Clin Transplant; 2011 Jun; 9(3):197-202. PubMed ID: 21649569
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease.
Franz RW; Shah KJ; Pin RH; Hankins T; Hartman JF; Wright ML
J Vasc Surg; 2015 Sep; 62(3):673-80. PubMed ID: 26304481
[TBL] [Abstract][Full Text] [Related]
12. [Autologous bone marrow-derived stem cell therapy in patients with severe peripheral arterial disorder].
Boda Z; Udvardy M; Farkas K; Tóth J; Jámbor L; Soltész P; Rázsó K; Oláh Z; Ilonczai P; Szarvas M; Litauszky K; Hunyadi J; Sipos T; Kappelmayer J; Veréb Z; Rajnavölgyi E
Orv Hetil; 2008 Mar; 149(12):531-40. PubMed ID: 18343769
[TBL] [Abstract][Full Text] [Related]
13. Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.
Moazzami K; Moazzami B; Roohi A; Nedjat S; Dolmatova E
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD008347. PubMed ID: 25525690
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.
Van Tongeren RB; Hamming JF; Fibbe WE; Van Weel V; Frerichs SJ; Stiggelbout AM; Van Bockel JH; Lindeman JH
J Cardiovasc Surg (Torino); 2008 Feb; 49(1):51-8. PubMed ID: 18212687
[TBL] [Abstract][Full Text] [Related]
15. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia.
Gu YQ; Zhang J; Guo LR; Qi LX; Zhang SW; Xu J; Li JX; Luo T; Ji BX; Li XF; Yu HX; Cui SJ; Wang ZG
Chin Med J (Engl); 2008 Jun; 121(11):963-7. PubMed ID: 18706241
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia.
Perin EC; Silva G; Gahremanpour A; Canales J; Zheng Y; Cabreira-Hansen MG; Mendelsohn F; Chronos N; Haley R; Willerson JT; Annex BH
Catheter Cardiovasc Interv; 2011 Dec; 78(7):1060-7. PubMed ID: 21594960
[TBL] [Abstract][Full Text] [Related]
18. Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies.
Rigato M; Monami M; Fadini GP
Circ Res; 2017 Apr; 120(8):1326-1340. PubMed ID: 28096194
[TBL] [Abstract][Full Text] [Related]
19. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia.
Ruiz-Salmeron R; de la Cuesta-Diaz A; Constantino-Bermejo M; Pérez-Camacho I; Marcos-Sánchez F; Hmadcha A; Soria B
Cell Transplant; 2011; 20(10):1629-39. PubMed ID: 22289660
[TBL] [Abstract][Full Text] [Related]
20. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
Gu Y; Zhang J; Qi L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
